Vanderbilt-Zambia Cancer Research Training Program (VZCARE)

范德比尔特-赞比亚癌症研究培训计划 (VZCARE)

基本信息

项目摘要

ABSTRACT The cancer burden in Zambia is increasing, making it one of the leading non-communicable causes of disability and premature death. This trend will continue and accelerate. However, cancer research in Zambia, particularly population-based research, is limited, primarily due to a lack of well-trained investigators, supportive research infrastructure, and adequate funding. Currently, Zambia has no cancer-specific research training programs to address the workforce gap. Vanderbilt University Medical Center (VUMC) and the University of Zambia (UNZA) are expanding their longstanding research training partnership to establish a new cancer epidemiology training program, the Vanderbilt-Zambia Cancer Research Training Program (VZCARE). The overall goal of VZCARE is to develop a cadre of researchers and educators equipped with modern knowledge and expertise to lead cancer epidemiology research and training in Zambia, to encourage US- based researchers to engage in cancer research in low- and middle-income countries, and to ensure long-term program impacts and sustainability. Specifically, VZCARE seeks to: 1. Train a cadre of researchers and educators (trainers) to conduct multidisciplinary cancer epidemiology research and build training capacity in Zambia, targeting faculty members and researchers from UNZA, University Teaching Hospital, Cancer Diseases Hospital, and the Zambia Ministry of Health. This will be accomplished via an intensive 3- month Visiting Faculty Scholars program at Vanderbilt, Zambia-based epidemiology workshops, and augmenting the UNZA PhD program with advanced cancer epidemiological curricula. 2. Train scientists and future leaders in cancer epidemiology research in Zambia. This will include US- and Zambia-based “sandwich” training and dual-mentored research for two Zambian PhD students and three Zambian postdoctoral trainees, and field research experience in Zambia for two US postdoctoral trainees. 3. Ensure and document VZCARE’s long-term impact. In addition to documenting the career development and research accomplishments of our trainees, we will provide continued support for their career development and foster collaborations beyond their supported training periods. With a very successful 23-year UNZA-Vanderbilt Training Partnership on HIV-related research and education, and Vanderbilt’s substantial global cancer epidemiology research and training programs, we are well positioned to launch this new training program with a focus on building world-class cancer epidemiology research and training in Zambia and promoting US investigators to engage in global cancer research.
摘要 赞比亚的癌症负担正在增加,使其成为导致残疾的主要非传染性原因之一。 以及过早死亡。这一趋势将继续并加速。然而,赞比亚的癌症研究, 特别是基于人口的研究有限,主要是由于缺乏训练有素的调查人员, 支持性的研究基础设施和充足的资金。目前,赞比亚还没有针对癌症的研究 解决劳动力缺口的培训计划。范德堡大学医学中心(VUMC)和 赞比亚大学(UNZA)正在扩大他们长期的研究培训合作伙伴关系,以建立一个新的 癌症流行病学培训计划,范德比尔特-赞比亚癌症研究培训计划(VZCARE)。 VZCARE的总体目标是培养一支拥有现代化技能的科研和教育工作者队伍 在赞比亚领导癌症流行病学研究和培训的知识和专业知识,以鼓励美国- 基地研究人员在低收入和中等收入国家从事癌症研究,并确保 计划的影响和可持续性。具体地说,VZCARE的目标是:1.培养一批研究人员和 教育工作者(培训者)进行多学科癌症流行病学研究和培训 在赞比亚的能力,目标是来自UNZA、大学教学医院、 癌症医院和赞比亚卫生部。这将通过密集的3- 赞比亚范德比尔特流行病学研讨会的访问学者计划,以及 用先进的癌症流行病学课程加强UNZA博士项目。2.培养科学家和 赞比亚癌症流行病学研究的未来领导者。这将包括总部位于美国和赞比亚的公司 为两名赞比亚博士生和三名赞比亚人提供“三明治”培训和双导师研究 两名美国博士后实习生,以及在赞比亚的实地研究经验。3.确保 并记录VZCARE的长期影响。除了记录职业发展和 对于学员的研究成就,我们将继续为他们的职业发展提供支持和 在其支持的培训期间之外促进协作。与23年来非常成功的UNZA-Vanderbilt 关于艾滋病毒相关研究和教育的培训伙伴关系和范德比尔特的实质性全球癌症 流行病学研究和培训计划,我们处于有利地位,可以启动这一新的培训计划 在赞比亚重点建设世界一流的癌症流行病学研究和培训,并推动美国 调查人员将从事全球癌症研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOUGLAS CORBETT HEIMBURGER其他文献

DOUGLAS CORBETT HEIMBURGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOUGLAS CORBETT HEIMBURGER', 18)}}的其他基金

Vanderbilt-Zambia Cancer Research Training Program (VZCARE)
范德比尔特-赞比亚癌症研究培训计划 (VZCARE)
  • 批准号:
    10596631
  • 财政年份:
    2022
  • 资助金额:
    $ 27.2万
  • 项目类别:
UNZA-Vanderbilt Training Partnership for HIV-NCD Research (UVP-2)
UNZA-范德比尔特 HIV-NCD 研究培训合作伙伴关系 (UVP-2)
  • 批准号:
    10440507
  • 财政年份:
    2015
  • 资助金额:
    $ 27.2万
  • 项目类别:
UNZA-VANDERBILT PARTNERSHIP FOR HIV-NUTRITION RESEARCH TRAINING (UVP)-HIV supplement
UNZA-范德比尔特 HIV 营养研究培训 (UVP) 合作伙伴关系 - HIV 补充剂
  • 批准号:
    9298881
  • 财政年份:
    2015
  • 资助金额:
    $ 27.2万
  • 项目类别:
UNZA-Vanderbilt Training Partnership for HIV-NCD Research (UVP-2)
UNZA-范德比尔特 HIV-NCD 研究培训合作伙伴关系 (UVP-2)
  • 批准号:
    10240755
  • 财政年份:
    2015
  • 资助金额:
    $ 27.2万
  • 项目类别:
UNZA-VANDERBILT PARTNERSHIP FOR HIV-NUTRITION RESEARCH TRAINING (UVP)
UNZA-范德比尔特艾滋病毒营养研究培训合作伙伴关系 (UVP)
  • 批准号:
    9301899
  • 财政年份:
    2015
  • 资助金额:
    $ 27.2万
  • 项目类别:
UNZA-Vanderbilt Training Partnership for HIV-NCD Research (UVP-2)
UNZA-范德比尔特 HIV-NCD 研究培训合作伙伴关系 (UVP-2)
  • 批准号:
    10618909
  • 财政年份:
    2015
  • 资助金额:
    $ 27.2万
  • 项目类别:
UNZA-VANDERBILT PARTNERSHIP FOR HIV-NUTRITION RESEARCH TRAINING (UVP)
UNZA-范德比尔特艾滋病毒营养研究培训合作伙伴关系 (UVP)
  • 批准号:
    9090201
  • 财政年份:
    2015
  • 资助金额:
    $ 27.2万
  • 项目类别:
UNZA-VANDERBILT PARTNERSHIP FOR HIV-NUTRITION RESEARCH TRAINING (UVP)
UNZA-范德比尔特艾滋病毒营养研究培训合作伙伴关系 (UVP)
  • 批准号:
    9313359
  • 财政年份:
    2015
  • 资助金额:
    $ 27.2万
  • 项目类别:
Vanderbilt-Zambia Network for Innovation in Global Health Technologies
范德比尔特-赞比亚全球健康技术创新网络
  • 批准号:
    8531372
  • 财政年份:
    2012
  • 资助金额:
    $ 27.2万
  • 项目类别:
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)
范德比尔特-埃默里-康奈尔-杜克全球健康研究员联盟 (VECDor)
  • 批准号:
    8672799
  • 财政年份:
    2012
  • 资助金额:
    $ 27.2万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.2万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了